We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Consumers may ask what real value is created by endless mergers and spin-offs masterminded by CEOs and bankers
Chemicals company has cut costs and reduced its asset footprint
US flavouring group seeks first-mover advantage with purchase of nutrition venture
Projections suggest $300m in annual cost savings and $400m of revenue benefits
New York company wins bidding against Kerry for nutrition and biosciences unit
Deterioration in recent years prompts new fears of retirement ‘time bomb’
Wave of deals across the diverse industry is being spurred by chance to cut costs
Activist demands more radical surgery after chemicals groups’ $143bn merger
Shareholders fear proposals might not maximise value after $142bn deal completed
Mega deal is first of three up for approval from EU watchdogs in agrichemical sector
Agrichemicals pair will offer to sell R&D capability to ease fears over $140bn merger
Concern merger would limit competition for supplies crucial to Europe’s farmers
A combination would be strategically sensible but financially difficult
Don’t just do something, sit there
Andrew Liveris set to leave next year following merger with DuPont
Chief executive to stand down after DuPont deal is completed
US chemical group’s earnings plunge 38 per cent in 2015
‘Devastating day’ for Delaware as 1,700 staff hit amid Dow Chemical merger savings plan
Boards must not let possible savings override industrial logic
The combination is intended as a stepping stone to a separation into three more focused companies
International Edition
